Santos da Silva Jorge 4

What Happened

• Santos da Silva Jorge, CEO of MoonLake Immunotherapeutics (MLTX), sold a total of 150,000 shares in open-market transactions.
• He disposed of 98,127 shares on 2026-04-10 at a weighted-average price of $18.41 for proceeds of $1,806,518, and 51,873 shares on 2026-04-13 at a weighted-average price of $18.23 for proceeds of $945,645, totaling $2,752,163.
• This was a sale (not a purchase); such sales are often routine and do not necessarily indicate company prospects.

Key Details

• Transaction dates and prices:
  • 2026-04-10: 98,127 shares sold @ $18.41 (weighted avg); reported price range $18.00–$19.55 (see footnote F2).
  • 2026-04-13: 51,873 shares sold @ $18.23 (weighted avg); reported price range $18.00–$18.41 (see footnote F3).
• Sales were made pursuant to Rule 144 under the Securities Act (footnote F1).
• The weighted-average prices reflect multiple trades; the filer will provide a per-price breakdown to the SEC or issuer upon request (F2, F3).
• Shares owned after the transactions are not specified in the information provided.
• Filing status: Form 4 was filed on 2026-04-14 and appears timely for the reported trade dates (not indicated as late).

Context

• These are open-market sales of already-held shares (no option exercises or awards reported). Sales by executives can be for many personal or tax reasons; they are factual disclosures rather than commentary on company fundamentals.